Table 3.

Adverse outcomes in 1051 patients with CABG with various CKD stages and degrees of proteinuria

CKD StagesOutcomes
AKI (n = 183)Need for RRT (n = 50)30-Day Mortality (n = 37)
NormalMildHeavyPbNormalMildHeavyPbNormalMildHeavyPb
Preserved eGFR (n = 631)9.5%13.8%24.4%0.0101.4%4.2%12.2%0.0012.1%1.8%9.8%0.010
Stage 3 (n = 359)13.0%30.1%36.9%0.0013.1%6.0%12.3%0.0293.1%6.8%3.1%0.266
Stage 4 (n = 62)46.7%40.0%37.5%0.83620.0%6.7%22.6%0.41013.3%6.7%6.3%0.690
Pa0.0080.0090.3490.0060.7430.3590.0280.0290.355
  • Preserved eGFR, eGFR ≥60 ml/min per 1.73 m2. P, the tests for linear trend across CKD categories (Pa) and across proteinuria categories (Pb).